Found 8 results. Export: Tagged | XML
Filters: author is Aarts  [Clear All Filters]
2008
Peeters, M.Y., Bras, L.J., DeJongh, J., Wesselink, R.M., Aarts, L.P., Danhof, M., Knibbe, C.A. , Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients, Clin Pharmacol Ther, vol. 83, no. 3, pp. 443-51. DOI
Peeters, M.Y., Aarts, L.P., Boom, F.A., Bras, L.J., Tibboel, D., Danhof, M., Knibbe, C.A. , Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients, Eur J Clin Pharmacol, vol. 64, no. 3, pp. 329-34. DOI
2005
Knibbe, C.A., Zuideveld, K.P., Aarts, L.P., Kuks, P.F., Danhof, M. , Allometric relationships between the pharmacokinetics of propofol in rats, children and adults, Br J Clin Pharmacol, vol. 59, no. 6, pp. 705-11. DOI
2004
Knibbe, C.A., Naber, H., Aarts, L.P., Kuks, P.F., Danhof, M. , Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients, Acta Anaesthesiol Scand, vol. 48, no. 3, pp. 302-7. DOI
2002
Knibbe, C.A., Zuideveld, K.P., DeJongh, J., Kuks, P.F., Aarts, L.P., Danhof, M. , Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%, Clin Pharmacol Ther, vol. 72, no. 6, pp. 670-84. DOI
2000
Knibbe, C.A., Aarts, L.P., Kuks, P.F., Voortman, H.J., Lie, A.H.L., Bras, L.J., Danhof, M. , Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery, Eur J Clin Pharmacol, vol. 56, no. 1, pp. 89-95.
1999
Knibbe, C.A., Koster, V.S., Aarts, L.P., Langemeijer, H.J., Danhof, M. , Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN, Pharm World Sci, vol. 21, no. 5, pp. 239-40.
Knibbe, C.A., Voortman, H.J., Aarts, L.P., Kuks, P.F., Lange, R., Langemeijer, H.J., Danhof, M. , Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection, Br J Clin Pharmacol, vol. 47, no. 6, pp. 653-60. DOI